Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
5
56%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
1(16.7%)
N/ANon-phased studies
5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(1)
Terminated(1)
Other(2)

Detailed Status

Recruiting4
unknown2
Completed1
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (16.7%)
N/A5 (83.3%)

Trials by Status

completed111%
recruiting444%
withdrawn111%
unknown222%
enrolling_by_invitation111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DEVICE
Total Trials
9